Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome

AIM OF THE STUDY: To evaluate the toxicity, clinical effectiveness and survival rate of transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin in patients with muscle invasive bladder cancer. MATERIAL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nowak-Sadzikowska, Jadwiga, Jakubowicz, Jerzy, Skóra, Tomasz, Pudełek, Katarzyna
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2013
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934068/
https://ncbi.nlm.nih.gov/pubmed/24596519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2013.35276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados